Skip to main content
. 2017 May 15;56(10):1193–1198. doi: 10.2169/internalmedicine.56.6998

Figure 4.

Figure 4.

The clinical course of Case 2, including the symptoms, the treatment, and the laboratory data. VCAP-AMP-VECP: cyclophosphamide, adriamycin, vincristine, vinblastine, ranimustine, etoposide, paraplatin and prednisolone regimen, MTX: methotrexate, Ara-C: cytarabine, ATL: adult T-cell leukemia